This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Randall, T D Articles by Corley, R B Search for Related Content PubMed PubMed Citation Articles by Randall, T D Articles by Corley, R B

Interleukin-5 (IL-5) and IL-6 define two molecularly distinct pathways of B-cell differentiation.

Department of Immunology, Duke University Medical Center, Durham, North Carolina 27710.

ABSTRACT

Interleukin-5 (IL-5) and IL-6 have both been reported to act as B-cell differentiation factors by stimulating activated B cells to secrete antibody. However, it has not been possible to directly compare the effects of these two lymphokines because of the lack of a suitable B-cell line capable of responding to both. We have identified a clonal, inducible B-cell lymphoma, CH12, that has this property. Both IL-5 and IL-6 can independently stimulate increases in steady-state levels of immunoglobulin and J-chain mRNA and proteins, and they both induce the differentiation of CH12 into high-rate antibody-secreting cells. Nevertheless, there are significant differences in the activities of these two lymphokines. First, while IL-6 acts only as a differentiation factor, IL-5 also augments the proliferation of CH12 cells. Second, the differentiation stimulated by IL-5 but not by IL-6 is partially inhibited by IL-4. Inhibition of IL-5-induced differentiation was not at the level of IL-5 receptor expression, since IL-4 did not inhibit IL-5-induced proliferation. Third, IL-5 but not IL-6 stimulated increased mouse mammary tumor proviral gene expression in CH12 cells. These results demonstrate that while both IL-5 and IL-6 may act as differentiation factors for B cells, they induce differentiation by using at least partially distinct molecular pathways. Our results also establish that B cells characteristic of a single stage of development can independently respond to IL-4, IL-5, and IL-6.

This article has been cited by other articles:

• Fagone, P., Sriburi, R., Ward-Chapman, C., Frank, M., Wang, J., Gunter, C., Brewer, J. W., Jackowski, S. (2007). Phospholipid Biosynthesis Program Underlying Membrane Expansion during B-lymphocyte Differentiation. J. Biol. Chem. 282: 7591-7605 [Abstract] [Full Text]  
• Doerre, S., Mesires, K. P., Daley, K. M., McCarty, T., Knoetig, S., Corley, R. B. (2005). Reductions in I{kappa}B{epsilon} and Changes in NF-{kappa}B Activity during B Lymphocyte Differentiation. J. Immunol. 174: 983-991 [Abstract] [Full Text]  
• Gass, J. N., Gifford, N. M., Brewer, J. W. (2002). Activation of an Unfolded Protein Response during Differentiation of Antibody-secreting B Cells. J. Biol. Chem. 277: 49047-49054 [Abstract] [Full Text]  
• Lee, B. O., Haynes, L., Eaton, S. M., Swain, S. L., Randall, T. D. (2002). The Biological Outcome of CD40 Signaling Is Dependent on the Duration of CD40 Ligand Expression: Reciprocal Regulation by Interleukin (IL)-4 and IL-12. J. Exp. Med. 196: 693-704 [Abstract] [Full Text]  
• Soro, P. G., Morales-A., P., Martinez-M., J. A., Morales-A., S., Copin, S. G., Marcos, M. A. R., Gaspar, M.-L. (1999). Differential Involvement of the Transcription Factor Blimp-1 in T Cell-Independent and -Dependent B Cell Differentiation to Plasma Cells. J. Immunol. 163: 611-617 [Abstract] [Full Text]  
• Reuss, F. U., Coffin, J. M. (1998). Mouse Mammary Tumor Virus Superantigen Expression in B Cells Is Regulated by a Central Enhancer within the pol Gene. J. Virol. 72: 6073-6082 [Abstract] [Full Text]